Literature DB >> 14482325

[Therapeutic use of Oxaphenamide].

N Ia ORMELI, R K SHAMSUTDINOVA.   

Abstract

Entities:  

Keywords:  CHOLAGOGUES AND CHOLERETICS/therapy; SALICYLAMIDES/therapy

Mesh：

Substances：

Year:  1962        PMID： 14482325

Source DB:  PubMed          Journal:  Med Zh Uzb        ISSN： 0025-830X


× No keyword cloud information.
  1 in total

1.  Preclinical validation and phase I trial of 4-hydroxysalicylanilide, targeting ribonucleotide reductase mediated dNTP synthesis in multiple myeloma.

Authors:  Yongsheng Xie; Yingcong Wang; Zhijian Xu; Yumeng Lu; Dongliang Song; Lu Gao; Dandan Yu; Bo Li; Gege Chen; Hui Zhang; Qilin Feng; Yong Zhang; Ke Hu; Cheng Huang; Yu Peng; Xiaosong Wu; Zhiyong Mao; Jimin Shao; Weiliang Zhu; Jumei Shi
Journal:  J Biomed Sci       Date:  2022-05-12       Impact factor: 12.771
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.